Related Experiment Videos

Penetration of aminoglycosides in uninfected pleural exudates and in pleural empyemas

J P Thys1, P Vanderhoeft, A Herchuelz

  • 1Infectious Diseases Clinic, Cliniques Universitaires de Bruxelles, Belgium.

Chest
|March 1, 1988
PubMed

Insights

Aminoglycoside antibiotics like gentamicin, netilmicin, and amikacin show high pleural fluid penetration but poor levels in empyema pus. This suggests challenges in treating pleural infections with these drugs.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Pulmonology

Background:

  • Pleural infections, particularly empyema, pose treatment challenges.
  • Aminoglycosides are commonly used antibiotics for bacterial infections.

Purpose of the Study:

  • To determine the concentrations and pleural penetration of gentamicin, netilmicin, and amikacin.
  • To compare drug levels in sterile pleural fluid versus purulent empyema pus.

Main Methods:

  • Single intravenous injection of gentamicin, netilmicin, and amikacin in patients.
  • Measurement of drug concentrations in pleural fluid and empyema pus.
  • Calculation of pleural penetration percentages.

Main Results:

  • High peak concentrations and penetration (>80%) in sterile pleural fluid for all three drugs.
  • Gentamicin and netilmicin were undetectable in empyema pus.
  • Amikacin showed lower peak concentrations (5.7 mg/L) and penetration (31.0%) in empyema pus compared to sterile fluid.

Conclusions:

  • Aminoglycoside concentrations are significantly lower in empyema pus than in sterile pleural fluid.
  • Poor pleural penetration and unfavorable local conditions in empyema may limit aminoglycoside efficacy.
  • Consideration of these factors is crucial for effective treatment of pleural infections.

Related Concept Videos